ICL Group Ltd. (ICL) is trading higher today as the market revisits the company’s most recent business update and outlook, which emphasized a 2026 adjusted EBITDA guidance range of $1.4 billion to $1.6 billion and ongoing strategy execution focused on specialty crop nutrition and specialty food solutions. The update also underscored portfolio optimization steps, including discontinuing previously announced projects to move further downstream into LFP battery cathode active materials while continuing to supply raw materials to battery customers. (investors.icl-group.com)

In its latest full-year report, ICL posted 2025 sales of $7.153 billion and adjusted EBITDA of $1.488 billion, alongside commentary that momentum is expected to carry into 2026. For investors, the mix shift toward higher-value specialty businesses matters because it can help reduce earnings volatility versus more commodity-exposed fertilizer swings, even as potash volumes remain a major driver. (investors.icl-group.com)

ICL also has a separate, longer-dated catalyst in the background: a binding agreement with the State of Israel that fixes consideration at $2.54 billion for the transfer of certain Dead Sea concession-related assets at the concession’s end in 2030, a step the company described as reducing uncertainty tied to the concession timeline. While not an immediate cash event, investors often treat reduced concession-risk as supportive to valuation and planning visibility. (financialreports.eu)

The next major scheduled catalyst is ICL’s next quarterly earnings release, which market calendars currently estimate for May 18, 2026 (estimated based on prior patterns, not confirmed by the company). Investors will be listening for any change in 2026 guidance, updates on specialty growth initiatives, and any progress on reviews of non-core assets referenced in the latest annual results materials. (marketbeat.com)